GRB10 as a pan-cancer biomarker linking oncogenic signaling, immunosuppression, and immunotherapy resistance.
Saved in:
| Title: | GRB10 as a pan-cancer biomarker linking oncogenic signaling, immunosuppression, and immunotherapy resistance. |
|---|---|
| Authors: | Guo H; Nanjing Drum Tower Hospital Group Suqian Hospital, SuQian, 223600, China. guohaoran0915@xzhmu.edu.cn.; The Affiliated Suqian Hospital of Xuzhou Medical University, SuQian, 223600, China. guohaoran0915@xzhmu.edu.cn., Chen J; Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, 215002, China. 20194232038@alu.suda.edu.cn. |
| Source: | Discover oncology [Discov Oncol] 2025 Dec 22; Vol. 16 (1), pp. 2269. Date of Electronic Publication: 2025 Dec 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2730-6011 |
|---|---|
| DOI: | 10.1007/s12672-025-04333-x |
